DEBORAH HOSPITAL FOUNDATION

Deborah Heart and Lung Center is a global leader in the field of cardiology, pulmonary, and vascular care. We offer a wide range of advanced surgical procedures and non-surgical alternatives for the diagnosis and treatment of cardiac, pulmonary, and vascular diseases in adults and children, including congenital and acquired heart defects.

Deborah offers a robust cardiovascular educational program, utilizing the latest technology, research, and clinical trials. Deborah is a teaching hospital and has the second largest cardiology fellowship program in the United States led by certified educators, including interventional cardiologists and vascular surgeons. Deborah’s clinical research department employs the brightest new talent and performs cutting-edge trials, making Deborah the site of many firsts.

Recognized consistently as a pioneer in patient care and innovative healing, Deborah stands out as the only hospital in the United States that treats adults and children yet has never rendered a bill to a patient. Deborah has always believed that there can be "No Price on Life" and that no one should be forced to make a medical decision based on their personal financial situation. Deborah has never billed a patient: No deductibles, no co-pays, and no balance billing. Our patients benefit from our unique business model so they can focus on recovery and wellness, not the financial impact of treatment costs.

Deborah Heart and Lung Center is a distinguished medical institution specializing in the prevention, diagnosis, research, and treatment of cardiac, pulmonary, and vascular diseases. Since its establishment in 1922, Deborah has gained regional and national recognition as a leader in specialized healthcare. Deborah has earned a reputation as a premier healthcare facility, sought after by individuals worldwide for its exceptional medical expertise.

As one of the foremost specialty care hospitals in the nation, Deborah offers advanced surgical procedures and non-surgical alternatives for the diagnosis and treatment of cardiac, pulmonary, and vascular diseases in adults, as well as congenital and acquired heart defects in both adults and children.

Deborah Heart and Lung Center is a certified Ventricular Assist Device (LVAD) facility, encompassing both "bridge-to-transplant" and "destination therapy" LVAD implants. It serves as the sole hospital LVAD procedure site in South Jersey.

The Left Ventricular Assist Device (LVAD) is a mechanical pump surgically implanted in patients to mitigate the progression of severe congestive heart failure. Functioning as a support mechanism, the LVAD assists a malfunctioning left ventricle in pumping blood. Patients who receive an LVAD are either awaiting a heart transplant, using it as a temporary measure ("bridge-to-transplant"), or rely on it as a long-term solution for heart failure ("destination therapy").

Deborah Heart and Lung Center is ranked as the #1 highest-volume Left Ventricular Assist Device (LVAD) implant center in the United States.

Deborah has earned the distinguished 3-star rating from the Society of Thoracic Surgeons (STS) for its patient care and outcomes in isolated coronary artery bypass grafting and isolated aortic valve replacement surgeries. This recognition makes Deborah one of the top cardiothoracic centers in the United States and Canada. The STS three-star rating is the highest designation awarded by the STS and is one of the most highly regarded overall measures of quality in health care.

Deborah Heart and Lung Center is an Alliance Member with the Cleveland Clinic, which is ranked #1 in the nation for heart care. As an alliance member, Deborah elevates cardiovascular care for patients in the region – allowing for the sharing of best practices, new treatments, and therapies. Patients benefit from:

Highest quality care
Sharing of best practices
Cutting edge technologies
Advances in treatments

Heart disease is the leading cause of death in the United States; it affects every segment of the population. It is the leading cause of death among all Americans, men, and women alike. It is also the leading cause of death among Whites and Blacks and the second leading cause of death among Hispanics and Asians. One person dies every 36 seconds in the U.S. from cardiovascular disease. About 659,000 Americans die from heart disease each year – accounting for one in every four deaths.

Over 60% of women believe their biggest health threat is breast cancer, but cardiovascular disease (Heart disease) kills six times as many women as breast cancer. Heart disease is the number one killer of women, causing one in three deaths each year. That is approximately one woman every minute.

Health care hardship access increases the odds by 47% of people having heart disease. People with a high degree of financial insecurity (those who said they frequently felt stressed about having enough money to pay their rent or mortgage) were more than twice as likely to have heart disease as those who considered themselves financially secure.

CARDIOLOGY AT DEBORAH
Deborah Heart and Lung Center specializes in a variety of cardiology treatments including general cardiology, cardio-thoracic surgery, congestive heart failure, interventional cardiology, and electrophysiology.

Additional services include the following:

Abdominal Aortic Aneurysm (AAA) Repair
Beating Heart Bypass Surgery
Coronary Artery Bypass Grafting (CABG)
Endoscopic Vein Harvesting
Minimally-Invasive Direct Coronary Artery Bypass (MIDCAB)
Off-Pump Coronary Artery Bypass Surgery (OPCAB)
Stents
Thoracic Aortic Aneurysm Surgery
Transcatheter Aortic Valve Replacement (TAVR)
Thoracic (Lung) Surgery
Aortic Valve Replacement

PEDIATRICS AT DEBORAH
The Children’s Heart Center at Deborah is a dedicated outpatient clinic with highly skilled pediatric cardiologists committed to helping children combat heart disease. It combines preventative and diagnostic management and a variety of treatment options to insure that pediatric patients are receiving the best care possible. The Children’s Heart Center at Deborah treats children from in-utero through adulthood and works with their families to address cardiovascular risk factors and diseases.

SERVICES INCLUDE
Outpatient Pediatric Cardiology
Pediatric Echocardiography
Pediatric Arrhythmia Program
Community Screenings for Sudden Cardiac Arrest

THE WOMEN’S HEART CENTER AT DEBORAH
Studies show that women continue to receive less cardiovascular care across the entire healthcare spectrum. The Women’s Heart Center at Deborah, addresses this diagnosis and treatment gap with earlier detection, comprehensive diagnostics, the most advanced treatment options, clinical trials, and effective rehabilitation services.

The Women’s Heart Center combines Deborah Heart and Lung Center’s expertise in treating heart and vascular disease with programs to help reduce stress; reduce weight; quit smoking; eat better; sleep more soundly; manage diabetes and educate women about the signs and symptoms of heart and vascular disease. The Women’s Heart Center has played a key role in numerous clinical research trials, including:

The PROMISE trial, which investigates non-invasive strategies and technologies to improve diagnosis and management of women with heart disease

The PROTECTION VI study, which looked at reducing radiation dosages in cardiac diagnosis

The LUCY study, which focused on peripheral arterial disease in women

TARGET POPULATION
Located in Browns Mills, NJ, Deborah primarily serves patients in New Jersey, Pennsylvania, New York, and Delaware. In addition, patients come to Deborah from all across the United States. Our primary service area includes Burlington, Ocean, and Monmouth Counties.

In southern New Jersey, there are 263,000 veterans. Deborah is one mile from the Joint Base McGuire-Dix-Lakehurst and cares for thousands of military and veteran patients each year through our HeroCare Connect Program.

In 2022, there were over 87,900 outpatient visits at Deborah. Eighty-nine percent of our patients ranged in age from adult to advanced-aged (40 to 85+), fifty-five percent male and forty-five percent female. The average length of stay was approximately 3 days. Twenty-five percent of our patients are of ethnic origin.